1. Home
  2. BDRX vs UPC Comparison

BDRX vs UPC Comparison

Compare BDRX & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$6.81

Market Cap

2.4M

Sector

Health Care

ML Signal

HOLD

Logo Universe Pharmaceuticals Inc.

UPC

Universe Pharmaceuticals Inc.

N/A

Current Price

$4.26

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BDRX
UPC
Founded
2000
1998
Country
United Kingdom
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BDRX
UPC
Price
$6.81
$4.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.6M
50.9K
Earning Date
09-12-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$19,293,003.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.58
$2.51
52 Week High
$92.00
$54.00

Technical Indicators

Market Signals
Indicator
BDRX
UPC
Relative Strength Index (RSI) 58.01 53.91
Support Level $4.00 $4.06
Resistance Level $8.94 $4.54
Average True Range (ATR) 1.09 0.36
MACD 0.33 0.13
Stochastic Oscillator 72.28 75.97

Price Performance

Historical Comparison
BDRX
UPC

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: